Updates

February 26, 2021February 24, 2021
A Farewell Note to My Beloved Readers

So, the time has come. Here I am, three years after I sat down for the first time to write my inaugural column for Lymphoma ... Read more
February 15, 2021February 11, 2021
A Light-giver Shares a Lesson in Emotional Honesty

Have you ever noticed how the people with the most light to give are often those who have endured the most suffering? I realized this ... Read more
February 1, 2021January 27, 2021
Embarking on a New Chapter While Cherishing the Value of Community

It’s surreal to ponder that our world has been living through a pandemic for a year now. That we’ve endured this strange sense of separation ... Read more
December 14, 2020December 9, 2020
Shedding My Sickness While Acknowledging Its Eternal Impact

Just before the world changed overnight in March, I wrote a column titled “The Paradox of Healing.” In it, I contemplated my feelings about returning ... Read more
November 16, 2020November 12, 2020
Sometimes Everything Works Out All Right

The other day, I chanced upon a poem called “Sometimes” that stopped me in my tracks and penetrated right through my rib cage and into ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

May 2, 2018

CHMP Recommends Approval of Generic Carmustine for Lymphoma, Brain Tumors

News

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the generic medication Carmustine Obvius (carmustine) for the treatment of non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, and brain tumors. The CHMP is EMA’s committee responsible ... Read more

Updates

A Farewell Note to My Beloved Readers

A Light-giver Shares a Lesson in Emotional Honesty

Embarking on a New Chapter While Cherishing the Value of Community

Shedding My Sickness While Acknowledging Its Eternal Impact

Sometimes Everything Works Out All Right

Let’s Not Forget the Superheroes

Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor

Can a Break From Routine Induce Healing?

Reflections on My ‘Re-birthday’ and the Past Year of Recovery

This Year Has Taught Me Gratitude

Total Happiness Is Unobtainable, and That’s OK

Subscribe to our mailing list

As I Befriend My Fear of Relapse, Fear Loses Its Power

How to Embrace Pain and Let It Transform You

My Quarantine Glow-up: Getting Fit After Cancer

Adcetris Plus Chemo Now First-line Treatment of Adults with sALCL in Europe

FDA Decision on Liso-cel, CAR T-cell Therapy for Large B-cell Lymphoma, Due in November

Cirmtuzumab-Imbruvica Yields ‘Encouraging’ Response Rates Against Mantle Cell Lymphoma, Ongoing Trial Shows

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Despite the Struggle, I Have Found Solace in Solitude

1st Patient Treated in Phase 1 Trial of ATG-019 for Lymphoma, Solid Tumors

Keytruda Prolongs Life Without Disease Worsening in Classical Hodgkin’s Lymphoma, Interim Data Confirm

Finding Beauty in the Brokenness

ME-401 Put on FDA’s Fast Track for Previously Treated Follicular Lymphoma

Zevalin Improves Survival of Non-Hodgkin’s Lymphoma Patients in Real-world Setting, Study Finds

As a Member of the Cancer Club, Coronavirus Is Not Fun

FDA Grants Orphan Drug Status to Umbralisib for Follicular Lymphoma

First Patient Treated in MB-106 CAR T-cell Trial Now Cancer Free, Mustang Says

CLR 131 Shows Anti-tumor Activity, Safety in Difficult-to-treat B-cell Lymphoma Trial

Tafasitamab Plus Revlimid Granted FDA Priority Review for Relapsed or Refractory DLBCL

The Paradox of Healing

Tipifarnib Granted FDA Fast Track Designation for T-cell Lymphomas

CHMP Recommends Approval of Generic Carmustine for Lymphoma, Brain Tumors

A Farewell Note to My Beloved Readers

A Light-giver Shares a Lesson in Emotional Honesty

Embarking on a New Chapter While Cherishing the Value of Community

Shedding My Sickness While Acknowledging Its Eternal Impact

Sometimes Everything Works Out All Right

Let’s Not Forget the Superheroes

Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor

Can a Break From Routine Induce Healing?

Reflections on My ‘Re-birthday’ and the Past Year of Recovery

This Year Has Taught Me Gratitude

Total Happiness Is Unobtainable, and That’s OK

Subscribe to our mailing list

As I Befriend My Fear of Relapse, Fear Loses Its Power

How to Embrace Pain and Let It Transform You

My Quarantine Glow-up: Getting Fit After Cancer

Adcetris Plus Chemo Now First-line Treatment of Adults with sALCL in Europe

FDA Decision on Liso-cel, CAR T-cell Therapy for Large B-cell Lymphoma, Due in November

Cirmtuzumab-Imbruvica Yields ‘Encouraging’ Response Rates Against Mantle Cell Lymphoma, Ongoing Trial Shows

Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

Despite the Struggle, I Have Found Solace in Solitude

1st Patient Treated in Phase 1 Trial of ATG-019 for Lymphoma, Solid Tumors

Keytruda Prolongs Life Without Disease Worsening in Classical Hodgkin’s Lymphoma, Interim Data Confirm

Finding Beauty in the Brokenness

ME-401 Put on FDA’s Fast Track for Previously Treated Follicular Lymphoma

Zevalin Improves Survival of Non-Hodgkin’s Lymphoma Patients in Real-world Setting, Study Finds

As a Member of the Cancer Club, Coronavirus Is Not Fun

FDA Grants Orphan Drug Status to Umbralisib for Follicular Lymphoma

First Patient Treated in MB-106 CAR T-cell Trial Now Cancer Free, Mustang Says

CLR 131 Shows Anti-tumor Activity, Safety in Difficult-to-treat B-cell Lymphoma Trial

Tafasitamab Plus Revlimid Granted FDA Priority Review for Relapsed or Refractory DLBCL

The Paradox of Healing

Video: BioNews’ Social Media Campaign Highlights #WhatMakesMeRare

Tipifarnib Granted FDA Fast Track Designation for T-cell Lymphomas

CHMP Recommends Approval of Generic Carmustine for Lymphoma, Brain Tumors